FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
Whitepaper

Financing Social Good – What the RBC Social Finance Initiative Has Taught Us

Admin Aug 28, 2026
Featured News

Fintech Enters a New Era as AI, Real-Time Payments and Embedded…

Whitepaper

New global retail banking data

Articles

India’s Fintech Market Crash: Is the Boom Turning Into a Reality…

Articles

Can Blockchain Revolutionize the Banking System?

Whitepaper

Why financial institutions need one-to-one messaging to build profitable customer…

Admin Aug 24, 2026
By taking advantage of today’s technologically advanced world, there are many opportunities for financial…
Featured News

Rising Grocery Prices Put Pressure on Indian Household Budgets as Food Inflation…

Admin Aug 21, 2026
India’s household budgets are coming under renewed pressure as rising prices of everyday groceries, vegetables,…
Featured News

Gold and Silver Prices Surge as Investors Turn to Precious Metals Amid Global…

Admin Aug 20, 2026
Gold and silver prices have once again moved higher in India, highlighting the continued strength and volatility…
Featured News

AI and Intelligent Payments Reshape the FinTech Industry in 2026

Admin Aug 18, 2026
The global FinTech industry is entering a new phase of transformation in 2026 as artificial intelligence,…
Featured News

Rising Tax Burden and Public Frustration: When Government Taxation Becomes a Daily…

Admin Aug 17, 2026
Government taxation remains one of the most important sources of public revenue, funding infrastructure,…
Featured News

FinTech’s Next Growth Wave: AI, Embedded Finance and Digital Trust Reshape the…

Admin Aug 14, 2026
The global FinTech industry is entering a new phase of transformation as artificial intelligence, embedded…
Whitepaper

Future of Finance: Review on the outlook for the UK financial system

Admin Aug 13, 2026
The Governor asked me last year to lead a review of the future of the UK’s financial system, and what it might…
Articles

FinTech and Employee F&F Settlement: How Digital Financial Platforms Are…

Admin Aug 12, 2026
The financial technology, or FinTech, industry is transforming the way businesses manage money, payments, payroll,…
Articles

How AI and Digital Innovation Are Transforming the Future of the FinTech Industry

Admin Aug 11, 2026
The financial technology industry is entering a new era. What began as a movement to make banking and payments…
Whitepaper

The Power of Ecosystems for Banking

Admin Aug 10, 2026
The rise of Banking as a Service (BaaS) and real-time payments (RTP) are pushing the era of digitalization to new…
Articles

The Rise of Fintech: Transforming the Financial Landscape

Admin Aug 7, 2026
Fintech, short for financial technology, refers to the innovative application of technology in financial…
Articles

Why Financial Services and Banks Need an Operational Data Layer

Admin Aug 5, 2026
Unlocking Real-Time Intelligence for the Future of Financial Services The financial services industry is…
Articles

FinTech Futures: How Media, Advertising & Marketing Are Shaping the Next…

Admin Aug 4, 2026
Introduction: Finance Is No Longer Just About Banking The financial services industry has undergone a…
Articles

Fintech and the Stock Market: How Technology Is Revolutionizing Modern Investing

Admin Aug 3, 2026
Discover how fintech is transforming the stock market through AI, algorithmic trading, robo-advisors, blockchain,…
Whitepaper

Shifting focus Risk culture is at the forefront of banking

Admin Jul 31, 2026
The new message this year is the almost universal focus on risk culture, with an emphasis on conduct, reflecting…
Whitepaper

Future of Banking Industry

Admin Jul 30, 2026
There may not be many striking features in this scenario, but let’s see what processes are running behind the…
Articles

Blockchain and Its Most Useful Applications in Finance

Admin Jul 29, 2026
Blockchain technology is notable for its transparent database, safe data, decentralized network, and cryptographic…
Articles

FinTech: Definition, Advantages of the FinTech Movement, and More

Admin Jul 28, 2026
The financial services industry is undergoing a profound transformation, driven by a wave of innovation and new…
Articles

Utilizing Procurement Tools for Businesses in the Modern Era

Admin Jul 27, 2026
In today’s fast-paced business landscape, effective procurement processes are pivotal for maintaining a…
Articles

How Fintech is Revolutionizing Personal Finance Management

Admin Jul 24, 2026
Financial technology (fintech) has dramatically changed the landscape of personal finance, offering consumers more…
Whitepaper

The Modernization of Payments and the New Bank Tech Company

Admin Jul 23, 2026
The writing is on the wall. Disruptive technologies, evolving consumer behaviors and expectations, innovative new…
Whitepaper

Central Bank Digital Currency Global Interoperability Principles

Admin Jul 21, 2026
Central banks have different motivations for exploring or developing central bank digital currency (CBDC), and the…
Articles

How to Calculate the Effect of Physical Risks on Finance

Admin Jul 20, 2026
Acute physical risks from climate change can be caused by storms or floods, or they can be chronic, resulting from…
Articles

Five things not to do while financial planning

Admin Jul 17, 2026
Many women rely on their parents or spouses for financial planning and investment responsibilities because it has…
Whitepaper

Artificial Intelligence, Machine Learning and Big Data in Finance

Admin Jul 16, 2026
Artificial Intelligence (AI) techniques are being increasingly deployed in finance, in areas such as asset…
Whitepaper

Plan Sponsor Reporting and Audit Guide

Admin Jul 15, 2026
Unlike many trusteed plans, a retirement plan using TIAA and CREF annuities may be funded, in whole or in part, by…
Whitepaper

Real-time payments: A perspective for payment system policy makers

Admin Jul 14, 2026
As the name suggests, real-time payment systems accelerate the speed at which funds are transferred between…
Articles

The Share Market and Systematic Investment Plans (SIPs): A Guide to Smart…

Admin Jul 13, 2026
The share market has long been a significant avenue for individuals seeking to build wealth through…
Whitepaper

Scaling Your Property Management Business With Payment Technology

Admin Jul 10, 2026
Property management is an industry that has seen steady yet significant growth over the past year. Obviously, the…
Articles

Banks slash interest rates on home loans: should you move your balance?

Admin Jul 9, 2026
Two banks, Bank of Baroda and Bank of Maharashtra, have recently reduced their interest rates for home loans amid…
Featured News

Figure Technologies Launches Ready Life Partnership to Increase Mortgage Access

Admin Jul 3, 2026
Figure Technologies, Inc., a leader in transforming financial services through the power of blockchain technology,…
Whitepaper

Building a Greenfield Digital Bank in the Fintech Era

Admin Jul 1, 2026
Gone are the days when customers would visit brick and mortar stores 3-5 times a week to complete their daily…
1 2 3 … 14 Next

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Financing Social Good – What the RBC Social Finance Initiative Has Taught Us
    • Fintech Enters a New Era as AI, Real-Time Payments and Embedded Finance Reshape Global Financial Services
    • New global retail banking data
    • India’s Fintech Market Crash: Is the Boom Turning Into a Reality Check?
    • Can Blockchain Revolutionize the Banking System?

    ARTICLE

    Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
    2026-11-05T12:30:00Z
    RESET-Myositis® registrational adult topline results anticipated in 2H27 with BLA submission in 1Q28, including Phase 1/2 juvenile dermatomyositis data for potential PRV eligibility and Phase 1/2 adult durability data


    SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights
    2026-11-05T12:30:00Z
    Adult and adolescent cohorts fully enrolled in registrational SAFEGUARD study of SAB-142; Pediatric cohort (ages 5–11) actively enrolling with overall enrollment on track for completion in Q4 2026


    Collegium Reports Third Quarter 2026 Financial Results; Reaffirms 2026 Guidance
    2026-11-05T12:30:00Z
    – Generated Record Quarterly Net Revenues of $216.3 Million, Up 3% Year-over-Year –


    Medicus Pharma to Present at BIO-Europe 2026
    2026-11-05T12:30:00Z
    Medicus Chief Medical Officer will Highlight Company’s Focus on Precision Oncology, Anchored by CD228V targeted ADC and Partner Ready Therapeutic Programs


    Cronos Group Reports 2026 Third Quarter Results
    2026-11-05T12:30:00Z
    Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count


    Dyne Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
    2026-11-05T12:30:00Z
    - Biologics License Application (BLA) for z-rostudirsen in exon 51 Duchenne muscular dystrophy (DMD) under priority review by FDA; PDUFA target action date of January 21, 2027 -


    LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide
    2026-11-05T12:30:00Z
    Eligible patients prescribed Zepbound® or Foundayo® through LifeMD can now receive authentic Lilly medicines at Lilly's self-pay prices through LifeMD's affiliated pharmacy


    Palvella Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
    2026-11-05T12:30:00Z
    FDA Accepts NDA for QTORIN™ Rapamycin and Grants Priority Review for Microcystic Lymphatic Malformations; PDUFA Target Action Date Set for February 28, 2027


    Newsweek Places KFSH Riyadh in Top 5% of World’s Best Hospitals & Clinics for Medical Tourism 2027
    2026-11-05T12:28:35Z
    RIYADH, Saudi Arabia, Nov. 05, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) in Riyadh has ranked among the top 5% of hospitals included in Newsweek’s...


    Addgene Integrates Plasmid and Viral Prep Catalog into Anthropic’s Claude for Life Sciences
    2026-11-05T12:15:00Z
    Addgene Model Context Protocol (MCP) connector enables researchers to search and compare Addgene materials directly within Claude


    Akebia Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
    2026-11-05T12:10:00Z
    Patients on Vafseo® (vadadustat) increased to approximately 11,500 at the end of Q3 2026 representing an increase of approximately 140% from the end of Q3 2025


    ProMIS Neurosciences to Participate in Upcoming Conferences in November
    2026-11-05T12:00:00Z
    CAMBRIDGE, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today...


    Kayak Therapeutics Announces IND Clearance for KT-300, a Potential First-in-Class TRIM7 Inhibitor for RAS-Driven Cancers
    2026-11-05T12:00:00Z
    HOUSTON and DURHAM, N.C., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Kayak Therapeutics, Inc. (“Kayak” or the “Company”), a clinical-stage biotechnology company developing novel approaches to targeted cancer therapy, today announced...


    Monte Rosa Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates
    2026-11-05T12:00:00Z
    Positive GFORCE-1 Phase 1 results showed MRT-8102 reduced key pathogenic drivers of atherosclerotic cardiovascular disease (ASCVD) to levels comparable to healthy volunteers across all three dose levels, with treatment-emergent adverse event...


    Opus Genetics Completes Dosing in Cohort 2 of Phase 1/2 Clinical Trial of OPGx-BEST1 Gene Therapy for Inherited Retinal Diseases
    2026-11-05T12:00:00Z
    Topline three-month data from Cohort 2 expected in the first quarter of 2027, with potential pivotal Phase 3 trial dosing anticipated in the second half of 2027


    Entrada Therapeutics Reports Third Quarter 2026 Financial Results
    2026-11-05T12:00:00Z
    -- All ELEVATE-44-201 Cohort 1 participants have completed open-label dosing, with data expected to be received by year-end 2026 ---- Company on track to report ELEVATE-44-201 Cohort 2 data in...


    Charming Medical Limited Announces Receipt of Nasdaq Delisting Determination Notice.
    2026-11-05T12:00:00Z
    Hong Kong, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Charming Medical Limited (Nasdaq: MCTA) (the “Company”), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, today announced that...


    Certara Reports Third Quarter 2026 Financial Results
    2026-11-05T12:00:00Z
    Certara delivers a solid quarter with double-digit software revenue growth


    Fate Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
    2026-11-05T12:00:00Z
    Safety profile presented at ASN Kidney Week 2026 across 29 autoimmune patients treated with a single dose of FT819 and fludarabine-free, less-intensive conditioning continues to be favorable, further supporting RECLAIM-LN


    Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
    2026-11-05T12:00:00Z
    Phase 3 AURORA trial of Descartes-08 in myasthenia gravis (MG) advances towards data readout expected in 1Q27 and biologics license application (BLA) filing planned for mid-2027


    OKYO Pharma to Present at the Stifel 2026 Healthcare Conference
    2026-11-05T12:00:00Z
    LONDON and NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and...


    Lexicon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Clinical Updates
    2026-11-05T12:00:00Z
    Phase 3 SONATA-HCM study substantially overenrolled; top-line data expected Q1 2027


    Climb Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates
    2026-11-05T12:00:00Z
    CLYM116 Phase 1 data in healthy volunteers showed sustained >90% free APRIL suppression and ~70% Gd-IgA1 reduction at 12 weeks after a single dose, supporting every-12-week dosing


    EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026
    2026-11-05T12:00:00Z
    WATERTOWN, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal...


    Healthcare Sharing Programs Accept New Members Year-Round, With No Open Enrollment Window
    2026-11-05T12:00:00Z
    Norfolk, VA, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Affordable Care Act (ACA) open enrollment, the annual window when most Americans can change or renew a health plan on the federal...


    Vima Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial for Parkinson’s Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
    2026-11-05T12:00:00Z
    -  First patient dosed in Phase 2 Vista PD study evaluating VIM0423, a potential first-in-class daily oral therapeutic, for the treatment of refractory tremor in adults with Parkinson’s disease


    Zenas BioPharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
    2026-11-05T12:00:00Z
    - PDUFA target action date of May 27, 2027, following FDA acceptance of obexelimab BLA submission for the treatment of IgG4-RD in August 2026 -


    C4 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
    2026-11-05T12:00:00Z
    Cemsidomide Phase 2 MOMENTUM Trial On Track to Complete Enrollment in 1Q 2027 with Initial ORR Data Expected in 2H 2027


    Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates
    2026-11-05T12:00:00Z
    WAYNE, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company focused on developing therapies targeting the IL-1β pathway for immune-mediated inflammatory diseases, today...


    iMDx to Release Third Quarter Results on November 16, 2026
    2026-11-05T12:00:00Z
    NASHVILLE, Tenn., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report third quarter 2026 financial results after the market closes...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.